4.5 Article

Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume 139, Issue 3, Pages 811-819

Publisher

SPRINGER
DOI: 10.1007/s10549-013-2588-9

Keywords

Breast neoplasms; Mortality; Prognosis; Retrospective cohort studies; Second primary

Categories

Funding

  1. Dutch Cancer Society (KWF) [EMCR 2008-4132]
  2. Academy Assistantship from the KNAW (Royal Netherlands Academy of Arts and Sciences)

Ask authors/readers for more resources

To compare overall survival between women with unilateral breast cancer (UBC) and contralateral breast cancer (CBC). Women with UBC (N = 182,562; 95 %) and CBC (N = 8,912; 5 %) recorded in the Netherlands Cancer Registry between 1989 and 2008 were included and followed until 2010. We incorporated CBC as a time-dependent covariate to compute the overall mortality rate ratio between women with CBC and UBC. Prognostic factors for overall death were examined according to age at first breast cancer. Women with CBC exhibited a 30 % increase in overall mortality (Hazard Ratio (HR), 95 % Confidence Interval: 1.3, 1.3-1.4) compared with UBC, decreasing with rising age at diagnosis of first breast cancer (< 50 years: 2.3, 2.2-2.5 vs. a parts per thousand yen70 years: 1.1, 1.0-1.1). Women older than 50 years at CBC diagnosis and diagnosed 2-5 years after their first breast cancer exhibited a 20 % higher death risk (1.2, 1.0-1.3) compared to those diagnosed within the first 2 years. In women younger than 50 years, the HR was significantly lower if the CBC was diagnosed > 5 years after the first breast cancer (0.7, 0.5-0.9). The prognosis for women with CBC significantly improved over time (2004-2008: 0.6, 0.5-0.7 vs. 1989-1993). Women with CBC had a lower survival compared to women with UBC, especially those younger than 50 years at first breast cancer diagnosis. A tailored follow-up strategy beyond current recommendations is needed for these patients who, because of their age and absence of known familial risk, are currently not invited for population-based screening.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Inge M. M. Lakeman, Mar D. M. Rodriguez-Girondo, Andrew Lee, Nandi Celosse, Merel E. Braspenning, Klaartje van Engelen, Irma van de Beek, Annemiek H. van der Hout, Encarna B. Gomez Garcia, Arjen R. Mensenkamp, Margreet G. E. M. Ausems, Maartje J. Hooning, Muriel A. Adank, Antoinette Hollestelle, Marjanka K. Schmidt, Christi J. van Asperen, Peter Devilee

Summary: This study explored the additive impact of a 313-variant-based Polygenic Risk Score (PRS313) in non-BRCA1/2 Dutch breast cancer families. The results showed a significant association between PRS313 and breast cancer, and the PRS313 had a substantial impact on breast cancer screening recommendations. These findings support the application of PRS313 in risk prediction for breast cancer families and families with pathogenic variants in moderate breast cancer risk genes.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort

Delal Akdeniz, Iris Kramer, Carolien H. M. van Deurzen, Bernadette A. M. Heemskerk-Gerritsen, Michael Schaapveld, Pieter J. Westenend, Adri C. Voogd, Agnes Jager, Ewout W. Steyerberg, Stefan Sleijfer, Marjanka K. Schmidt, Maartje J. Hooning

Summary: Lobular and lobular mixed primary breast cancer histology are associated with modestly increased risk of contralateral breast cancer (CBC), and personalized risk assessment needs to consider the histology of the primary cancer as well as the impact of systemic therapy.

CANCER MEDICINE (2023)

Article Biochemistry & Molecular Biology

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

Gisella Figlioli, Amandine Billaud, Thomas U. Ahearn, Natalia N. Antonenkova, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Marinus J. Blok, Natalia Bogdanova, Bernardo Bonanni, Barbara Burwinkel, Nicola J. Camp, Archie Campbell, Jose E. Castelao, Melissa H. Cessna, Stephen J. Chanock, Kamila Czene, Peter Devilee, Thilo Doerk, Christoph Engel, Mikael Eriksson, Peter A. Fasching, Jonine D. Figueroa, Marike Gabrielson, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Anna Gonzalez-Neira, Felix Grassmann, Pascal Guenel, Melanie Gundert, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Patricia A. Harrington, Wei He, Peter Hillemanns, Antoinette Hollestelle, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, Agnes Jager, Anna Jakubowska, Elza K. Khusnutdinova, Yon-Dschun Ko, Vessela N. Kristensen, Annika Lindblom, Jolanta Lissowska, Jan Lubinski, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, William G. Newman, Nadia Obi, Mihalis Panayiotidis, Muhammad U. Rashid, Valerie Rhenius, Matti A. Rookus, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Reijo Sironen, Melissa C. Southey, Maija Suvanto, Rob A. E. M. Tollenaar, Ian Tomlinson, Therese Truong, Lizet E. van der Kolk, Elke M. van Veen, Barbara Wappenschmidt, Xiaohong R. Yang, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, Douglas F. Easton, Michael Lush, Kyriaki Michailidou, Paul D. P. Pharoah, Qin Wang, Muriel A. Adank, Marjanka K. Schmidt, Irene L. Andrulis, Jenny Chang-Claude, Heli Nevanlinna, Georgia Chenevix-Trench, D. Gareth Evans, Roger L. Milne, Paolo Radice, Paolo Peterlongo

Summary: Evidence from the BRIDGES study suggests that germline protein truncating variants (PTVs) in FANCM are associated with increased risk of ER-negative and triple-negative breast cancer (TNBC), particularly for those with a family history. This study further investigates the association between FANCM missense variants (MVs) and breast cancer risk using the BRIDGES study, analyzing a total of 689 MVs. The results indicate that FANCM MVs may be low/moderate risk factors for ER-negative and TNBC subtypes of breast cancer.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

Stefanie H. Mueller, Alvina G. Lai, Maria Valkovskaya, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, Joe Dennis, Michael Lush, Zomoruda Abu-Ful, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Volker Arndt, Kristan J. Aronson, Annelie Augustinsson, Thais Baert, Laura E. Beane Freeman, Matthias W. Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Hermann Brenner, Sara Y. Brucker, Saundra S. Buys, Jose E. Castelao, Tsun L. Chan, Jenny Chang-Claude, Stephen J. Chanock, Ji-Yeob Choi, Wendy K. Chung, Sarah Colonna, Sten Cornelissen, Fergus J. Couch, Kamila Czene, Mary B. Daly, Peter Devilee, Thilo Dork, Laure Dossus, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, A. Heather Eliassen, Christoph Engel, D. Gareth Evans, Peter A. Fasching, Olivia Fletcher, Henrik Flyger, Manuela Gago-Dominguez, Yu-Tang Gao, Montserrat Garcia-Closas, Jose A. Garcia-Saenz, Jeanine Genkinger, Aleksandra Gentry-Maharaj, Felix Grassmann, Pascal Guenel, Melanie Gundert, Lothar Haeberle, Eric Hahnen, Christopher A. Haiman, Niclas Hakansson, Per Hall, Elaine F. Harkness, Patricia A. Harrington, Jaana M. Hartikainen, Mikael Hartman, Alexander Hein, Weang-Kee Ho, Maartje J. Hooning, Reiner Hoppe, John L. Hopper, Richard S. Houlston, Anthony Howell, David J. Hunter, Dezheng Huo, Abctb Investigators, Hidemi Ito, Motoki Iwasaki, Anna Jakubowska, Wolfgang Janni, Esther M. John, Michael E. Jones, Audrey Jung, Rudolf Kaaks, Daehee Kang, Elza K. Khusnutdinova, Sung-Won Kim, Cari M. Kitahara, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Katerina Kubelka-Sabit, Allison W. Kurian, Ava Kwong, James Lacey, Diether Lambrechts, Loic Le Marchand, Jingmei Li, Martha Linet, Wing-Yee Lo, Jirong Long, Artitaya Lophatananon, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Keitaro Matsuo, Dimitrios Mavroudis, Usha Menon, Kenneth Muir, Rachel A. Murphy, Heli Nevanlinna, William G. Newman, Dieter Niederacher, Katie M. O'Brien, Nadia Obi, Kenneth Offit, Olufunmilayo Olopade, Andrew F. Olshan, Hakan Olsson, Sue K. Park, Alpa Patel, Achal Patel, Charles M. Perou, Julian Peto, Paul D. P. Pharoah, Dijana Plaseska-Karanfilska, Nadege Presneau, Brigitte Rack, Paolo Radice, Dhanya Ramachandran, Muhammad U. Rashid, Gad Rennert, Atocha Romero, Kathryn J. Ruddy, Matthias Ruebner, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Marjanka K. Schmidt, Rita K. Schmutzler, Michael O. Schneider, Christopher Scott, Mitul Shah, Priyanka Sharma, Chen-Yang Shen, Xiao-Ou Shu, Jacques Simard, Harald Surowy, Rulla M. Tamimi, William J. Tapper, Jack A. Taylor, Soo Hwang Teo, Lauren R. Teras, Amanda E. Toland, Rob A. E. M. Tollenaar, Diana Torres, Gabriela Torres-Mejia, Melissa A. Troester, Therese Truong, Celine M. Vachon, Joseph Vijai, Clarice R. Weinberg, Camilla Wendt, Robert Winqvist, Alicja Wolk, Anna H. Wu, Taiki Yamaji, Xiaohong R. Yang, Jyh-Cherng Yu, Wei Zheng, Argyrios Ziogas, Elad Ziv, Alison M. Dunning, Douglas F. Easton, Harry Hemingway, Ute Hamann, Karoline B. Kuchenbaecker

Summary: This study identified 14 genes associated with breast cancer using gene-based aggregation analysis, including two newly discovered genes FMNL3 and AC058822.1. Furthermore, associations with established candidate genes like ESR1 were found through the collaboration of multi-ancestral cohorts, highlighting the importance of diversifying study cohorts. These findings provide new insights into the development of breast cancer.

GENOME MEDICINE (2023)

Editorial Material Dermatology

The important but difficult exercise of getting valid descriptive skin cancer data

Esther de Vries

BRITISH JOURNAL OF DERMATOLOGY (2023)

Review Oncology

EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy

Marjanka K. Schmidt, Jennifer E. Kelly, Anne Bredart, David A. Cameron, Jana de Boniface, Douglas F. Easton, Birgitte Offersen, Fiorita Poulakaki, Isabel T. Rubio, Francesco Sardanelli, Rita Schmutzler, Tanja Spanic, Britta Weigelt, Emiel J. T. Rutgers

Summary: After a unilateral breast cancer diagnosis, more and more patients are choosing to have contralateral prophylactic mastectomy (CPM), the removal of the healthy breast. Breast cancer specialists need to provide guidance to women considering CPM. This manifesto discusses the challenges of CPM and offers recommendations to improve outcomes for women with unilateral breast cancer.

EUROPEAN JOURNAL OF CANCER (2023)

Article Health Care Sciences & Services

Factors associated with suffering from dying in patients with cancer: a cross-sectional analytical study among bereaved caregivers

Angelica Arango-Gutierrez, Socorro Moreno, Martin Rondon, Lucia Arroyo, Liliana Ardila, Fabian Alexander Leal Arenas, Jose A. Calvache, Esther de Vries

Summary: This study aimed to explore the associations between the level of suffering of cancer patients who died and received care in three Colombian hospitals with patient, tumor, treatment, and care characteristics. The results showed that factors associated with a higher level of suffering include unclear treatment information, procedures inconsistent with the patient's wishes, outpatient palliative care, and a younger age at death.

BMC PALLIATIVE CARE (2023)

Article Health Care Sciences & Services

Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study

Salvatore Vaccarella, Damien Georges, Freddie Bray, Ophira Ginsburg, Hadrien Charvat, Pekka Martikainen, Henrik Bronnum-Hansen, Patrick Deboosere, Matthias Bopp, Mall Leinsalu, Barbara Artnik, Valentina Lorenzoni, Esther De Vries, Michael Marmot, Paolo Vineis, Johan Mackenbach, Wilma Nusselder

Summary: This study collected and analyzed whole-of-population cancer-specific mortality data by education level and sex across 18 countries in Europe during 1990-2015. The results showed that lower-educated individuals have higher mortality rates for almost all types of cancer compared to their more highly-educated counterparts. The magnitude of inequalities varied greatly by country and over time, and lung cancer was the largest contributor to overall cancer mortality inequalities. These findings highlight the importance of addressing socioeconomic inequalities in cancer in Europe.

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Oncology

Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis

Lonneke A. van Tuijl, Maartje Basten, Kuan-Yu Pan, Roel Vermeulen, Luetzen Portengen, Alexander de Graeff, Joost Dekker, Mirjam I. Geerlings, Adriaan Hoogendoorn, Femke Lamers, Adri C. Voogd, Jessica Abell, Philip Awadalla, Aartjan T. F. Beekman, Ottar Bjerkeset, Andy Boyd, Yunsong Cui, Philipp Frank, Henrike Galenkamp, Bert Garssen, Sean Hellingman, Martijn Huisman, Anke Huss, Trynke R. de Jong, Melanie R. Keats, Almar A. L. Kok, Steinar Krokstad, Flora E. van Leeuwen, Annemarie I. Luik, Nolwenn Noisel, N. Charlotte Onland-Moret, Yves Payette, Brenda W. J. H. Penninx, Ina Rissanen, Annelieke M. Roest, Rikje Ruiter, Robert A. Schoevers, David Soave, Mandy Spaan, Andrew Steptoe, Karien Stronks, Erik R. Sund, Ellen Sweeney, Emma L. Twait, Alison Teyhan, W. M. Monique Verschuren, Kimberly D. van der Willik, Judith G. M. Rosmalen, Adelita V. Ranchor

Summary: A meta-analysis of individual participant data from 18 cohorts found no associations between depression or anxiety and most types of cancer, except for lung cancer and smoking-related cancers. The associations with lung and smoking-related cancers were attenuated when adjusting for known risk factors.

CANCER (2023)

Article Oncology

The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia

Isaac Chayo, Claudia Janeth Uribe Perez, Esther De Vries, Paulo S. Pinheiro

Summary: Cervical cancer remains a significant cause of death in Colombia. This study investigated the relationship between socioeconomic status and health insurance affiliation with cervical cancer survival in Bucaramanga, Colombia. The results showed that lower socioeconomic status and subsidized health insurance were associated with lower 5-year overall survival rates. These disparities remained even within Colombia's universal healthcare system.

CANCER EPIDEMIOLOGY (2023)

Article Health Care Sciences & Services

Barriers and facilitators to palliative care for patients with non-curable cancer in Colombia: perspectives of allied health and social care professionals

Cindy V. Mendieta, Esther de Vries, Maria Elizabeth Gomez-Neva, Angela Maria Munoz-Escudero, Jose Andres Calvache, Tracey Mcconnell

Summary: This study aims to explore the barriers and facilitators to palliative care for patients with non-curable cancer in Colombia from the perspective of Allied Health and Social Care Professionals (AHSCP). The results showed that there are misconceptions about palliative care, which is mainly due to the lack of inclusion of this area in the educational programs of health professionals and AHSCPs, along with limited supply and access to palliative care, especially in rural areas.

BMC PALLIATIVE CARE (2023)

Article Psychology, Multidisciplinary

End of Life in Patients With Advanced Non-curable Cancer: Patient Considerations Around the Moment of Death

Socorro Moreno, Mauricio Medina-Rico, Katalina Osorio Clavijo, Nicole A. Rodriguez, Victor M. Vicuna Jimenez, Jose A. Calvache, Esther de Vries

Summary: This research provides limited knowledge about the preferences of Colombian patients with advanced cancer regarding their final moments, place of death, and post-death wishes. The study conducted 23 in-depth interviews with patients of different age groups. The findings showed that while many participants desired a peaceful death, the topic of death itself was largely uncomfortable to discuss. Socioeconomic and geographical factors significantly influenced the wishes and preferences expressed by the participants.

OMEGA-JOURNAL OF DEATH AND DYING (2023)

Article Health Care Sciences & Services

Co-Designing a Strategy for Implementing the SPARC Holistic Needs Assessment Tool in the Colombian Clinical Context

Cindy V. Mendieta, Esther de Vries, Jose Andres Calvache, Sam H. Ahmedzai, Gillian Prue, Tracey Mcconnell, Joanne Reid

Summary: This article introduces the implementation strategy workshop for SPARC-Sp in Colombia. Participants identified the need for PC education, clarification, and professional capacity building. They also recognized the need for adaptations to SPARC-Sp to address the low literacy of the population and specificities of the healthcare system in Colombia.

HEALTHCARE (2023)

Article Oncology

External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer

Yuwei Wang, Annegien Broeks, Daniele Giardiello, Michael Hauptmann, Katarzyna Jozwiak, Esther A. Koop, Mark Opdam, Sabine Siesling, Gabe S. Sonke, Nikolas Stathonikos, Natalie D. ter Hoeve, Elsken van der Wall, Carolien H. M. van Deurzen, Paul J. van Diest, Adri C. Voogd, Willem Vreuls, Sabine C. Linn, Gwen M. H. E. Dackus, Marjanka K. Schmidt

Summary: This study validated the reliability of the PREDICT breast cancer prognostic model and assessed its clinical utility in young women with node-negative breast cancer. The results showed that PREDICT was not reliable in predicting outcomes for this patient subset and further updates are needed.

EUROPEAN JOURNAL OF CANCER (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study

Kristien B. I. M. Keymeulen, Sandra M. E. Geurts, Loes F. S. Kooreman, Lucien E. M. Duijm, Sanne Engelen, Sigrid Vanwetswinkel, Ernest Luiten, Sabine Siesling, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen

Summary: Breast MRI at primary DCIS diagnosis can detect additional synchronous cDCIS and cIBC, and is associated with a higher rate of metachronous cDCIS without decreasing the rate of metachronous cIBC. This finding is most evident in younger patients.

EUROPEAN RADIOLOGY (2023)

No Data Available